Hire Education: Recruiting Rooted in Transparency and Honesty

Despite recession fears, the US job market is still advantageous for candidates. According to NBC, the great resignation is still in full swing, leaving many job openings. Recruiters are the liaison between clients and candidates. They help candidates navigate their needs and negotiate prospects.

Ashli Zimmerman, National Account Manager and Senior Recruiter at Catapult Solutions, said “Transparency is one of the most important factors when it comes to being a recruiter.” She understands that different candidates have different priorities, and getting to the motivating factors for each candidate will help her put them forward for the best-fitting roles.

Transparency is fundamental to success in recruiting and woven throughout the process. The recruiter and candidate have to be equally transparent. “It’s so important to be upfront about compensation or any other caveats about the role,” said Drew Cumbey, a Catapult Solution’s IT Recruiter. Recruiters need to be upfront about the basics and deal-breakers of the role, like compensation, benefits, and on-site or remote expectations. To help understand a new candidate’s desires, Cumbey likes to run through a thought experiment with them. He poses the question that if two roles tick the boxes on the candidate’s basic desires, what would motivate the candidate to take one position over another.

This dialogue prevents a communication breakdown or mismatched roles. “It gets to the root of what they [the candidates] are looking for. What gets them out of bed every day,” said Cumbey.

Zimmerman poses that this transparency helps the recruiter advocate for a candidate with the client. “Being able to bring that [the candidate’s motivators] to your client and say, ‘if this candidate is who you want to hire, these are their expectations,’” said Zimmerman. The better recruiters know their candidates, the better they can position them to interested clients.

The honesty and transparency Catapult Solutions uses for every search help them create symbiotic relationships for future employees and employers. Aiming for symbiotic relationships “saves people time and puts people where they need to be,” said Cumbey. Symbiosis is key to long-tenured job placements. Compared to, “parasitic relationships, how long is that going to last?” asked Cumbey.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More